Investment Tips for Top Stock by Research Expert

Research Head (MONEY MAKER RESEARCH & INVESTMENT ADVISOR PVT LTD) is having a view that one can go long in Avenue mart.

“Avenue mart is the stock which I would advocate traders to buy this stock in a range of 1020 to1025 with a price target of 1070 and stop loss placed below 970.

The Company has recorded another steady year of growth, despite performing in a highly competitive environment in the Retail Sector. Company has opened 21 new stores during the year under review, taking the total store count to 131 across the country.

The Company’s total income on Standalone basis was Rs.1, 191,240.76 Lakh compared to previous year''s Rs.859, 522.66 Lakh, registering a steady growth of 38.59% on a year over year basis. The Company has earned Standalone Net Profit of Rs.48, 263.85 Lakh

Avenue mart were closed 0.52 per cent up today at Rs 994.60 on NSE.

Money Maker Research News - The Stock Market Next Week

The stock market may remain volatile in the week ahead as traders roll over positions in the futures & options (F&O) sector from the near month August 2017 series to Sept 2017 series. The near month July 2017 derivatives contract ceases on Thursday, 31 August 2017.

Auto stocks will be expected to be in focus as because auto companies will start their reporting sales volume data for August 2017, starting from Friday, 1 Sept 2017.

Further, the government will unveil data on Q1 June 2017 GDP on Thursday, 31 August 2017, the impact of which will be visible in the coming week. India's GDP grown moderately of 6.1% in fourth quarter March 2017.

The GDP growth slowed down moderately from 7% growth recorded in the last quarter and 8.7% surge posted in the corresponding quarter last year. Globally, a good attention will be focused on Federal Reserve boss Janet Yellen, with expectations for some clues about the bank's plans.

MoneyMaker Research News - Stocks Tips: Pharma stocks gain

Pharma stocks in Nifty opened on Thursday in a positive note, trading higher by 1.43 percent at 8,738 levels on NSE in the morning hours, with Cadila Healthcare moving the top gainer in the index, by 4.94%.

Divi’s Lab was trading higher by 2.81 percent at Rs 656 per share, also Sun Pharma soared by 2.02% at Rs 478 per share. Lupin was trading up by 1.56%, Aurobindo Pharma higher by 1.25% and Cipla was up by 1.06% among others, while Dr Reddy Laboratoreis’s was the top loser in the index, down by 0.38% at Rs 2,023 per share and Glaxo Smith Kline was trading lower by 0.35% at Rs 2,382 per share.

Meanwhile, the benchmark indices Nifty was trading up by 0.6% at 9,858 levels and Sensex was trading higher by 16 points at 31,583 levels at 10.50 am, today. Indian rupee opened at 64.03 per dollar and was trading at 64.07 per dollar, up 0.07 percent from its last close of 64.11.